This inventor holds 1 USPTO granted patent. Top assignee: A-Fem Medical Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Paul Andrew Mueggler: Innovator in Microporous Solid Phase Materials
Introduction
Paul Andrew Mueggler is an accomplished inventor based in Portland, Oregon. He has made significant contributions to the field of microporous solid phase materials, particularly in the context of assays for detecting analytes in test samples. His innovative work has led to the development of technologies that are both stable and effective in various conditions.
Latest Patents
Mueggler holds a patent for "Covalent bonding of molecules to an activated solid phase material." This invention describes microporous solid phase materials that are suitable for lateral flow and other assays. These materials are designed to remain stable under varying humidity levels and can form stable covalent bonds with molecules containing free primary or secondary amine groups or sulfhydryl groups. The patent also discusses chemically derivatized solid phase materials and conjugates that include such materials. Additionally, it provides examples of lateral flow devices for the quantitative or semi-quantitative determination of analytes in biological samples.
Career Highlights
Mueggler is associated with A-Fem Medical Corporation, where he continues to apply his expertise in the development of innovative medical technologies. His work has been instrumental in advancing the capabilities of diagnostic assays, making them more reliable and efficient.
Collaborations
Mueggler has collaborated with notable colleagues, including Robert L. Buck and Huiying Wang. These partnerships have contributed to the successful development and implementation of his patented technologies.
Conclusion
Paul Andrew Mueggler is a notable inventor whose work in microporous solid phase materials has the potential to significantly impact the field of medical diagnostics. His innovative approaches and collaborations continue to drive advancements in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile